Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Bristol Myers Squibb Stock Rises
Bristol Myers Beats $6.4 Billion Lawsuit Over Delayed Cancer Drug
(Reuters) - Bristol Myers Squibb won the dismissal on Monday of a $6.4 billion lawsuit claiming it cheated former Celgene shareholders by delaying federal approval for the cancer drug Breyanzi and two other drugs developed by Celgene.
Bristol Myers Squibb Stock Rises After Schizophrenia Drug Gets FDA Approval
Key Takeaways Bristol Myers Squibb's drug to treat schizophrenia was approved for use by the Food and Drug Administration.The pharmaceutical firm called Cobenfy the first new treatment for the illness in decades.
FDA approves Bristol Myers Squibb's schizophrenia drug, the first new type of treatment in decades
The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with schizophrenia.
6m
on MSN
FDA Approves groundbreaking drug for schizophrenia treatment
On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.
Business Wire
3d
U.S. Food and Drug Administration Approves Bristol Myers Squibb’s COBENFY™ (xanomeline and trospium chloride), a First-In-Class Muscarinic Agonist for the Treatment of ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
4h
Cobenfy: The First New Schizophrenia Drug in Decades
The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Pete Rose dies at 83
NBA Hall of Famer dies
Helene wreaks havoc
‘Ring of fire’ eclipse in Oct
Blocks songs from artists
Grammy-winning singer dies
Illegal cloning sentencing
NYC tunnel shutdown
Lose 'superhero' trademark
37 militants killed in Syria
Defensive Player of the Year
Sells stake in DirecTV
Three PFLP leaders killed
Mich. nuclear plant to restart
Signals more rate cuts
Nepal floods: Death toll rises
Ozzie Virgil Sr. dies at 92
US wins Presidents Cup
Comer subpoenas Mayorkas
Seeks bribery dismissal
Israel announces operation
To sue Google, Samsung
US port strike looms
Line Fire prompts evacuation
$567M Taiwan defense aid
Red Sox honor radio voice
'Sing Sing' actor exonerated
Feedback